Page last updated: 2024-09-03

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and amyloid beta-peptides

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide has been researched along with amyloid beta-peptides in 1 studies

Compound Research Comparison

Studies
(5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide)
Trials
(5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide)
Recent Studies (post-2010)
(5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide)
Studies
(amyloid beta-peptides)
Trials
(amyloid beta-peptides)
Recent Studies (post-2010) (amyloid beta-peptides)
73083,257481,626

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Briyal, S; Gulati, A; Philip, T1

Other Studies

1 other study(ies) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and amyloid beta-peptides

ArticleYear
Endothelin-A receptor antagonists prevent amyloid-β-induced increase in ETA receptor expression, oxidative stress, and cognitive impairment.
    Journal of Alzheimer's disease : JAD, 2011, Volume: 23, Issue:3

    Topics: Amyloid beta-Peptides; Animals; Cognition Disorders; Dansyl Compounds; Endothelin A Receptor Antagonists; Gene Expression Regulation; Male; Oxidative Stress; Peptide Fragments; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A

2011